about
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene familySevere deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.Transplantation outcomes for severe combined immunodeficiency, 2000-2009.Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort.Whole-exome sequencing reveals a rapid change in the frequency of rare functional variants in a founding population of humans.Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences.Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age.Survey on retransplantation criteria for patients with severe combined immunodeficiency.A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.ICON: the early diagnosis of congenital immunodeficiencies.Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice.Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.Limited sampling strategies for estimating intravenous and oral cyclosporine area under the curve in pediatric hematopoietic stem cell transplantation.Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells.Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma.CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.A child who was feverish for 2 years.Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases.Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform.Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency?Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis.Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation.Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study.Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency.Improved quality of life with home therapy with subcutaneous immunoglobulins for patients with secondary hypogammaglobulinaemia.Patient with X-linked phenotype of SCID, markedly skewed maternal X-inactivation, but normal common gamma chain (CD132) gene ORF sequence.Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency.Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.How i treat primary haemophagocytic lymphohistiocytosis.SCIg vs. IVIg: let’s give patients the choice!.Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotypeFunctional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosisChronic Active Gastritis in X-linked Lymphoproliferative Disease
P50
Q28200813-5FB450D7-E25A-4519-8BDA-027BEC3BC31AQ33346993-2F1C7E18-DD16-4111-9250-66421258C3F8Q34279715-18276119-DCE9-4BCB-A27E-15E9BB54BA5DQ34455916-391D914B-E6F9-409E-B05A-40CD896CFF56Q35004530-3E520255-1545-4EF3-B009-D71545C6D5F3Q35879930-F43D7925-E639-497D-AAAA-DEF5A8F96C49Q36065396-06A7DEA5-5BC6-4761-9C5D-0565276D281DQ37649786-AADF1167-50B0-4C12-B421-D48B81D8284BQ37734244-01F1C9DA-48C4-472A-A1EA-33B4D953466AQ38195246-D7BD2923-BDCD-439E-BB77-740587D84E37Q38962963-F2349B9D-348D-493F-A06B-C9187192F1A8Q39023786-9EE3CEB8-82FE-440E-A92F-0D6F6D20A9CAQ39125689-409B36F9-184D-4C93-95ED-68BBDC81C109Q39139115-86DA81A4-4503-43A8-8E4C-B374C0B7AA21Q39279652-E0DE0083-FBEB-42BB-9537-531F7348A611Q39296574-2F8F43B5-34C2-45FB-B5BD-47672AD37D1AQ39362601-DFA5EEF0-9467-40DD-8C50-3DA0B8C6A0C8Q39384559-053F1A43-AF0B-4F1B-B749-3225620A86DFQ40663585-6A63646E-A2F3-4232-A50F-1062EE64F69FQ41210615-DEDBC1FE-AB3E-44AD-9B7F-582BCA7F75D7Q43099980-E0BF9CAD-11D4-4F59-82A5-ABBF0981BBF1Q43640569-54C43579-DFDD-4F2B-953F-8BBB3346485CQ44269084-AF047609-ECF1-4C0D-9E77-336AAF9BECD0Q44566189-FB19E3AC-78F3-46F9-A03F-4CF0170A4BD8Q44634443-46C07CDA-D2DB-491E-8F44-E88D2DD6EC73Q45128775-C23637B1-6C69-4BF9-9F87-224435886B51Q45392910-B0019FCC-BCBC-4D9B-9B4C-E0B44907FA0BQ45626273-E1674A24-FB06-4D9C-A75A-DDD92547843DQ45764462-EAD6A4B0-413F-4824-8DF6-F43240AB59EAQ47093913-3E83C8AC-E297-4AAC-820D-2A7E2158A2A5Q47108669-BB305307-3E13-4A6F-9FDF-E3D8B79A637CQ49107589-531D27EC-CBD8-4D03-8E44-E73520E33470Q50774043-90DD3917-3165-4A76-BD47-2349489F10FBQ51193284-21F1C46A-F8A7-47F1-AC2E-88FCCB3B8884Q53641943-4AADD605-5DD0-43ED-8BD4-18A964063336Q54210212-9AEBC255-F98C-429A-BEF2-066851D99F07Q55618341-A9352877-00DC-4EAE-92B5-5B1C6C000E0EQ56688674-F3716F85-A6E9-425A-8DDE-0F9319A059A5Q56941325-F8F39D47-D6AD-4391-A0A5-34E9C252323EQ57965180-1E5EDEE2-F649-41A4-80B7-B83D932EC33E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elie Haddad
@ast
Elie Haddad
@en
Elie Haddad
@es
Elie Haddad
@nl
Elie Haddad
@sl
type
label
Elie Haddad
@ast
Elie Haddad
@en
Elie Haddad
@es
Elie Haddad
@nl
Elie Haddad
@sl
prefLabel
Elie Haddad
@ast
Elie Haddad
@en
Elie Haddad
@es
Elie Haddad
@nl
Elie Haddad
@sl
P106
P21
P31
P496
0000-0003-2446-6879
P569
2000-01-01T00:00:00Z